Adaptive immunity is the body's targeted defense system that develops after exposure to specific pathogens. It contrasts with innate immunity, which is present from birth and responds non-specifically.
Active Immunity: Your own immune system produces antibodies and memory cells.
Passive Immunity: Borrowed immunity (e.g., from mother via placenta or antibody injections).
Natural Immunity: Acquired through natural exposure to pathogens.
Artificial Immunity: Induced by vaccines or booster shots.
Development Time: Adaptive immunity typically takes about 28 days to fully develop a robust memory response.
Type | Origin | Maturation Site | Function | Pathogen Type Targeted |
---|---|---|---|---|
B-cells | Bone marrow | Bone marrow | Create antibodies | Pathogens in blood (extracellular) |
T-cells | Bone marrow | Thymus | Attack infected cells directly | Pathogens inside cells (intracellular) |
Antigen: A foreign substance that triggers an immune response (usually proteins or polysaccharides).
Epitope: The specific site on an antigen recognized by B or T cell receptors.
Antibody (Immunoglobulin/Ig): A protein produced by B cells to bind antigens and neutralize or mark pathogens.
Diversity:
1 million B-cell receptor types
10 million T-cell receptor types
Enables recognition of vast array of pathogens.
Self-Tolerance:
Prevents attack on own body.
Immunological Memory:
Primary Response: Slower (10–17 days), first exposure.
Secondary Response: Faster (2–7 days), upon re-exposure.
Clonal Expansion:
Activation causes B/T cells to divide:
Effector cells: Active fighters.
Memory cells: Long-lived cells for faster future response.
Receptors shaped like a “Y” that bind directly to antigens.
Do not need infected cells to display antigens.
B cells:
Wait until encountering a matching antigen.
Bind to it and become activated.
Proliferate and produce antibodies.
Antibodies help neutralize pathogens in blood and lymph.
Receptors not Y-shaped; bind only to antigen fragments presented by other cells.
Types:
Helper T-cells (CD4+): Activate B cells and cytotoxic T-cells.
Cytotoxic T-cells (CD8+): Kill infected cells directly.
Require antigen-presenting cells (APCs) or infected cells to show antigen fragments via MHC molecules.
Detect antigens on APCs.
Release cytokines that:
Stimulate cytotoxic T-cells (cell-mediated response).
Stimulate B-cells (humoral response).
Kill infected cells using:
Perforin: Creates pores in infected cell membranes.
Granzymes: Trigger apoptosis (cell death).
Require activation signals from helper T-cells.
Upon activation:
Multiply and differentiate into plasma cells.
Secrete antibodies that:
Neutralize pathogens.
Tag them for destruction by other immune cells.
A protein cascade that:
Neutralizes viruses by preventing cell entry.
Opsonizes bacteria to enhance phagocytosis.
Forms pores in foreign cells, causing lysis (bursting).
Introduce a harmless form of a pathogen to the body.
Stimulates the adaptive immune system without causing disease.
Leads to immunological memory and rapid future responses.
Type | Description | Example |
---|---|---|
Live Attenuated | Weakened but live organisms | MMR, Sabin polio, yellow fever |
Inactivated | Killed organisms | Salk polio, rabies |
Subunit | Part of the pathogen (protein) | Hepatitis B, Hib |
DNA | Injected DNA encoding antigens (in animals) | Veterinary use only |
mRNA | mRNA delivers instructions to make antigen | COVID-19 vaccines |
Antigenic drift: Small mutations → new strains each year (e.g., flu).
Antigenic shift: Large recombination events → pandemics.
Strain replacement: Less common strain becomes dominant after vaccination suppresses the more common one.
If a critical mass is immune, the disease cannot spread easily.
Measured by R₀ (basic reproduction number):
If R₀ = 4, each person could infect 4 others.
Vaccinating enough people lowers spread even for the unvaccinated.